Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the appointment of Bijan Nejadnik, M.D., as Chief ...
Five issued U.S. patents cover the combination of ImmunityBio’s IL-15 receptor agonist (NAI) with Bacillus Calmette-Guérin ...
Gossamer Bio, Inc. (NASDAQ: GOSS) (the “Company”), a biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH ...
Positive PROSERA CT FRI Results Demonstrated Multiple Statistically Significant Treatment Effects, Including Novel Signals Correlated with Clinical Outcomes -- Gossamer Announces Commencement of ...
New identities advance a modern approach to evidence generationDURHAM, N.C.--(BUSINESS WIRE)--Target RWE and NoviSci, two ...
SHELTON, CT / ACCESS Newswire / May 18, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, emphasizes the ...
GOTHENBURG, SE / ACCESS Newswire / May 18, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Hôpital La Pitié-Salpêtrière (Sorbonne University) in Paris, France, has, since the approval of a ...
The global topical adhesives market is expected to witness steady expansion over the next five years, growing at a CAGR of around 6%. The market growth is being supported by rising surgical procedure ...
MMJ BioPharma Cultivation Exposed a Fundamental Constitutional Defect Inside the DEA. Now the Same Defective Administrative System Is Expected to Handle the Most Consequential Drug Rule making in a ...
NFC Forum, the global standards body for Near Field Communication (NFC) technology, has launched a Healthcare Special Interest Group (SIG), underscoring the new and emerging use cases for secure, ...
Global Clinical Trial Supplies Market OverviewThe global clinical trial supplies market is anticipated to expand at a steady ...
Hematology Market OverviewThe global hematology market is projected to grow at a CAGR of approximately 3–5% through 2027.